Cargando…

Comparison of Circumferential Pulmonary Vein Isolation and Antiarrhythmic Drug Therapy in Patients with Atrial Fibrillation

INTRODUCTION: The aim of this study was to evaluate quality of life after circumferential pulmonary vein isolation (CPVI) compared with antiarrhythmic drug therapy (ADT) in treating atrial fibrillation (AF). CPVI is now a common therapy in AF, but few studies have focused on the effect of CPVI on qu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yanmin, Sharma, Deepak, Du, Fawang, Li, Guangping, Xu, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare Communications 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107441/ https://www.ncbi.nlm.nih.gov/pubmed/25135157 http://dx.doi.org/10.1007/s40119-012-0003-y

Ejemplares similares

Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes
por: Calvo, Naiara, et al.
Publicado: (2010)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation
por: Miao, Yuxia, et al.
Publicado: (2021)

Bachmann's Bundle Modification in Addition to Circumferential Pulmonary Vein Isolation for Atrial Fibrillation: A Novel Ablation Strategy
por: Sun, Jiaqi, et al.
Publicado: (2023)

Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation
por: Verrier, Richard L., et al.
Publicado: (2020)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

Inducibility of atrial tachyarrhythmias after circumferential pulmonary vein isolation in patients with paroxysmal atrial fibrillation: clinical predictor and outcome during follow-up
por: Satomi, Kazuhiro, et al.
Publicado: (2008)

Remote magnetic versus manual catheter navigation for circumferential pulmonary vein ablation in patients with atrial fibrillation
por: Lüthje, Lars, et al.
Publicado: (2011)

Aberrant Pulmonary Vein Draining to Left Atrial Roof in a Patient Undergoing Percutaneous Circumferential Pulmonary Vein Isolation
por: Nazari, Neshat, et al.
Publicado: (2013)

Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation
por: Winkle, Roger A., et al.
Publicado: (2012)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
por: Hwang, Inseok, et al.
Publicado: (2021)

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
por: Hwang, Inseok, et al.
Publicado: (2022)

Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study
por: Mun, Hee-Sun, et al.
Publicado: (2012)

Clinical Implications of Unmasking Dormant Conduction After Circumferential Pulmonary Vein Isolation in Atrial Fibrillation Using Adenosine: A Systematic Review and Meta-Analysis
por: Chen, Cheng, et al.
Publicado: (2019)

Wide Antral Circumferential Re-Ablation for Recurrent Atrial Fibrillation after Prior Pulmonary Vein Isolation Guided by High-Density Mapping Increases Freedom from Atrial Arrhythmias
por: Hartl, Stefan, et al.
Publicado: (2023)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden
por: Dan, Gheorghe-Andrei
Publicado: (2020)

Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease
por: Pantlin, Peter G., et al.
Publicado: (2020)

Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs
por: Park, Yoon Jung, et al.
Publicado: (2023)

Revisiting the Role of Antiarrhythmic Drugs in Prevention of Atrial Fibrillation Recurrence: A Single Center Retrospective Review
por: Mascarenhas, Daniel AN, et al.
Publicado: (2018)

The Association Between the Use of Antiarrhythmic Drugs in Non-Valvular Atrial Fibrillation and Patient Prognosis Using Data from the China Atrial Fibrillation (China-AF) Registry
por: Hou, Xiao-Xia, et al.
Publicado: (2019)

Recurrent atrial fibrillation after pulmonary vein isolation: Box it or not?
por: Barnett, Adam S., et al.
Publicado: (2021)

Comparison of radiofrequency ablation and antiarrhythmic drug for the treatment of atrial fibrillation: A protocol for systematic review and meta-analysis
por: Deng, Junping, et al.
Publicado: (2022)

Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation
por: Wang, Amy
Publicado: (2012)

Time‐dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses
por: Carstensen, Helena, et al.
Publicado: (2018)

Knots to untie: anticoagulant and antiarrhythmic therapy after ablation for atrial fibrillation
por: Stazi, Filippo
Publicado: (2020)

Evaluation of Index of Cardio-Electrophysiological Balance in Patients With Atrial Fibrillation on Antiarrhythmic-Drug Therapy
por: Afsin, Abdulmecit, et al.
Publicado: (2021)

US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report
por: Tardos, Jonathan G., et al.
Publicado: (2021)

Wide area circumferential ablation for pulmonary vein isolation using radiofrequency versus laser balloon ablation
por: Skeete, Jamario, et al.
Publicado: (2022)

Left atrial function after epicardial pulmonary vein isolation in patients with atrial fibrillation
por: Bagge, Louise, et al.
Publicado: (2017)

Early markers of atrial fibrillation recurrence after pulmonary vein isolation
por: Lanters, Eva A. H., et al.
Publicado: (2020)

Neurocognitive function in patients with atrial fibrillation undergoing pulmonary vein isolation
por: Zwimpfer, Leon, et al.
Publicado: (2022)

Pulmonary vein isolation alone versus pulmonary vein isolation with additional extensive ablation for paroxysmal and persistent atrial fibrillation
por: Junarta, Joey, et al.
Publicado: (2022)

Atrial Tachycardias Arising from Ablation of Atrial Fibrillation: A Proarrhythmic Bump or an Antiarrhythmic Turn?
por: Shah, Ashok J., et al.
Publicado: (2010)

Effects of antiarrhythmics on atrial high rate episodes and progression to clinical atrial fibrillation (ANTI-AHRE)
por: Simovic, S, et al.
Publicado: (2023)

Efficacy of functional substrate map-guide approach for wide circumferential pulmonary vein isolation
por: Kobori, A, et al.
Publicado: (2023)

Antiarrhythmic and Electrophysiologic Effects of Flecainide on Acutely Induced Atrial Fibrillation in Healthy Horses
por: Haugaard, M.M., et al.
Publicado: (2014)

Undiagnosed sleep apnea in patients with atrial fibrillation: An underutilized opportunity for antiarrhythmic management
por: Hereijgers, Maartje J.M., et al.
Publicado: (2022)

The adjunctive effect for left pulmonary vein isolation of vein of Marshall ethanol infusion in persistent atrial fibrillation
por: Huang, Lihong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2emu4kddi0bl4cas23nlhdoq7c